0001213900-26-054473
SEC filingRevenue rose meaningfully year-over-year, but gross margin turned negative and operating losses widened significantly due to under-absorbed fixed costs from lower production volumes and acquisition-related expenses.
Revenue for Q1 FY2026 totaled $3.7M, a substantial increase from $39.0K in Q1 FY2025. This growth reflects the Company’s execution of its long-term strategy to acquire complementary businesses, including Luminar Semiconductor, Inc. (LSI) in February 2026 and NuCrypt. While the authoritative financial packet confirms revenue growth, it does not allocate specific contributions from these acquisitions — only that they occurred and are part of the broader commercial expansion.
Gross profit was -$721.0K, resulting in a gross margin of -19.5%. As stated in Item 2 of Management’s Discussion and Analysis, this decline was largely due to under-absorption of fixed costs stemming from lower production volumes at existing facilities. Operational signals confirm that near-term underutilization of production facilities is expected to depress gross margins, and management explicitly links this dynamic to current cost behavior — not pricing, mix, or external market shifts.
Net cash used in operating activities was -$9.4M, up from -$4.4M in Q1 FY2025. Capital expenditures totaled $1.8M, supporting ongoing infrastructure development, including the Arizona Chips Facility and planning for 'FAB 2'. Free cash flow was -$11.2M, underscoring the capital intensity of the Company’s hardware and optical chip fabrication roadmap. As noted in Item 1A (Risk Factors), the business remains capital-intensive, and additional funding will be required for equipment and facilities.
Management reiterates in Item 2 that losses and higher operating expenses are expected for the foreseeable future. Investment in research and development, go-to-market programs, and facility scaling — particularly the integration of LSI and the evolution of manufacturing capacity — will continue to shape near-term financial performance. Execution outcomes across these initiatives will directly influence product cost, time-to-market, and the longer-term margin profile.